Search Results - "Malshy, K."

Response to shared decision making in prostate cancer screening: Different perspective of public health physicians and urologists by Golijanin, B., Malshy, K., Bhatt, V., Homer, A., Ochsner, A., Wales, R., Khaleel, S., Mega, A., Pareek, G., Hyams, E.

Get full text

Can endoscopic appearance, selective cytology and pathological sampling during ureteroscopy accurately predict tumor grade of upper-tract urothelial carcinoma? by Malshy, K., Hoffman, A., Sadeh, O., Aro, T., Kastin, A., Goldin, O., Amiel, G.E., Mullerad, M.

Get full text

Comparing lifespan of artificial urinary sphincters in preirradiated patients: Transcorporal vs. standard placement by Malshy, K., Marthi, S., Ortiz, R., Golijanin, B., Miller, K., Hartsell, L., Cancian, M.

Get full text

P322 - Comparison of the incidence of clinically significant prostate cancer in patients with isolated peripheral vs. transitional zone PIRADS 3 lesions by Malshy, K., Ochsner, A., Ortiz, R., Golijanin, B., Khaleel, S., Eaton, S., Golijanin, D., Hyams, E.

Get full text

Comparison of the incidence of clinically significant prostate cancer in patients with isolated peripheral vs. transitional zone PIRADS 3 lesions by Malshy, K., Ochsner, A., Ortiz, R., Golijanin, B., Khaleel, S., Eaton, S., Golijanin, D., Hyams, E.

Get full text

P086 - Comparing lifespan of artificial urinary sphincters in preirradiated patients: Transcorporal vs. standard placement by Malshy, K., Marthi, S., Ortiz, R., Golijanin, B., Miller, K., Hartsell, L., Cancian, M.

Get full text

A0716 - Preliminary results of first-in-human cryotherapy for non-muscle invasive bladder cancer by Hoffman, A., Nativ, O., Malshy, K., Sadeh, O., Mullerad, M., Kochavi, E., Amiel, G.E.

Get full text

Preliminary results of first-in-human cryotherapy for non-muscle invasive bladder cancer by Hoffman, A., Nativ, O., Malshy, K., Sadeh, O., Mullerad, M., Kochavi, E., Amiel, G.E.

Get full text

Pembrolizumab in BCG refractory non-muscle invasive bladder cancer is associated with high rates of adverse events and discontinuation of treatment by Golijanin, B., Malshy, K., Bhatt, V., Lagos, G., Khaleel, S., Ali, A., DeSouza, A., Chenga, L., Mega, A., Golijanin, D.

Get full text

P263 - Pembrolizumab in BCG refractory non-muscle invasive bladder cancer is associated with high rates of adverse events and discontinuation of treatment by Golijanin, B., Malshy, K., Bhatt, V., Lagos, G., Khaleel, S., Ali, A., DeSouza, A., Chenga, L., Mega, A., Golijanin, D.

Get full text

P252 Preliminary results of first-in-human intra-vesical cryotherapy of non-muscle-invasive bladder cancer by Hoffman, A., Malshy, K., Sadeh, O., Nativ, O., Kochavi, E., Amiel, G.E.

Get full text